1. Home
  2. JSPR
  3. JSPR News

Latest Jasper Therapeutics Inc. (JSPR) News on November 18, 2024

Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria

GlobeNewswire

a month ago

Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria

Business Wire

5 months ago

Form 8.3 - Darktrace plc

Share on Social Networks: